---
title: "BLCO.US (BLCO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BLCO.US/news.md"
symbol: "BLCO.US"
name: "BLCO.US"
parent: "https://longbridge.com/en/quote/BLCO.US.md"
datetime: "2026-03-12T05:37:28.242Z"
locales:
  - [en](https://longbridge.com/en/quote/BLCO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BLCO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BLCO.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/BLCO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BLCO.US/news.md)


# BLCO.US (BLCO.US) — Related News

### [Bausch Health Companies (TSE:BHC) Stock Price Down 1.1%  - Here's What Happened](https://longbridge.com/en/news/278491717.md)
*2026-03-10T04:44:11.000Z*
> Bausch Health Companies (TSE:BHC) shares fell 1.1% to C$7.25 during mid-day trading, with a trading volume decline of 25

### [Stocks in Play: Bausch + Lomb Corporation](https://longbridge.com/en/news/278403815.md)
*2026-03-09T13:52:19.000Z*
> 09:48 AM EST - Bausch + Lomb Corporation : Today announced the first event in an R&D “Teach-in” webinar series that will

### [Bausch + Lomb Launches R&D “Teach-in” Webinar Series | BLCO Stock News](https://longbridge.com/en/news/278380568.md)
*2026-03-09T03:15:00.000Z*
> Bausch + Lomb Corporation (NYSE/TSX: BLCO) has announced the launch of an R&D "Teach-in" webinar series to provide insig

### [Assessing Bausch + Lomb (BLCO) Valuation After Strong Q4 Growth And Vision 27 Margin Progress](https://longbridge.com/en/news/277302800.md)
*2026-02-28T12:25:48.000Z*
> Bausch + Lomb (BLCO) reported record Q4 2025 revenue and adjusted EBITDA growth, driven by pharmaceuticals and premium p

### [Breaking Down Bausch & Lomb: 6 Analysts Share Their Views](https://longbridge.com/en/news/276365203.md)
*2026-02-19T18:01:20.000Z*
> Bausch & Lomb (NYSE:BLCO) received mixed ratings from 6 analysts over the past three months, with an average 12-month pr

### [Bausch + Lomb (BLCO) Loss Narrows To US$28m As Margin Repair Narrative Gains Traction](https://longbridge.com/en/news/276306483.md)
*2026-02-19T06:29:29.000Z*
> Bausch + Lomb (NYSE:BLCO) reported a Q3 FY 2025 revenue of US$1.3 billion and a basic EPS loss of US$0.08, narrowing its

### [Bausch + Lomb Signals Profitable Growth After Record Year](https://longbridge.com/en/news/276291639.md)
*2026-02-19T00:28:49.000Z*
> Bausch + Lomb Corporation reported record Q4 revenue of $1.405 billion, a 7% increase, and full-year sales of $5.101 bil

### [Bausch + Lomb | 10-K: FY2025 Revenue Beats Estimate at USD 5.101 B](https://longbridge.com/en/news/276280367.md)
*2026-02-18T22:22:18.000Z*
### [](https://longbridge.com/en/news/276277150.md)
*2026-02-18T21:30:34.000Z*
> Bausch Health Companies shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results.